High throughput RNAi screening identifies ID1 as a synthetic sick/lethal gene interacting with the common TP53 mutation R175H

Author：            

Publisher： Spandidos Publications

ISSN： 1021-335X

Source： Oncology Reports, Vol.31, Iss.3, 2014-01, pp. : 1043-1050

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

A New Germline TP53 Gene Mutation in a Family With Li-Fraumeni Syndrome

By Dockhorn-Dworniczak B.   Wolff J.   Poremba C.   Schafer K.-L.   Ritter J.   Gullotta F.   Jurgens H.   Bocker W.  

European Journal of Cancer, Vol. 32, Iss. 8, 1996-07 ,pp. : 1359-1365

Elsevier

Access to resources Recommend Favorite

TP53 Mutation in Ovarian Carcinoma

By Murphy M.   McManus D.T.   Toner P.G.   Russell S.E.H.  

European Journal of Cancer, Vol. 33, Iss. 8, 1997-07 ,pp. : 1281-1283

Elsevier

Access to resources Recommend Favorite

Late-Onset Common Cancers in a Kindred with an Arg213Gln TP53 Germline Mutation

By Ruijs Mariëlle   Verhoef Senno   Wigbout Gea   Pruntel Roelof   Floore Arno   Jong Daphne   Veer Laura   Menko Fred  

Familial Cancer, Vol. 5, Iss. 2, 2006-06 ,pp. : 169-174

Springer Publishing Company

Access to resources Recommend Favorite

Frequent TP53 Gene Alterations (Mutation, Allelic Loss, Nuclear Accumulation) in Primary Non-small Cell Lung Cancer

By Shipman R.   Schraml P.   Colombi M.   Raefle G.   Dalquen P.   Ludwig C.  

European Journal of Cancer, Vol. 32, Iss. 2, 1996-02 ,pp. : 335-341

Elsevier

Access to resources Recommend Favorite

TP53 Gene Mutation Status in Pretreatment Biopsies of Oesophageal Adenocarcinoma Has No Prognostic Value

By Soontrapornchai P.   Elsaleh H.   Joseph D.   Hamdorf J.M.   House A.K.   Iacopetta B.  

European Journal of Cancer, Vol. 35, Iss. 12, 1999-11 ,pp. : 1683-1687

Elsevier

Access to resources Recommend Favorite